Connect with us

Hi, what are you looking for?


Back pain to bedridden


By Bronte H. Lacsamana

WHEN FREQUENT and persistent back pain greatly reduces one’s mobility, doesn’t improve with rest, and disturbs sleep, a chronic illness called axial spondyloarthritis (AxSpA) could be the culprit.

“If detected late, there is really deformity and it’s debilitating. It impacts patients’ most productive years,” said Dr. Evan Glenn S. Vista, a rheumatologist at St. Luke’s Medical Center, explaining the effects of the inflammatory disease that involves the spine and the joints that connect the spine to the pelvis.

“Even if it does not equate to the number of Filipinos with, say, hypertension or diabetes, this subset of patients in the population will be able to contribute to society if their AxSpA is controlled properly,” he added at a recent webinar on bones and joints.

There are two types of AxSpA: non-radiographic (nr-axSpA) and radiographic, also known as ankylosing spondylitis (AS). The biggest difference between the two is that nr-axSpA doesn’t show up as spinal damage on a scan (such as an X-ray or magnetic resonance imaging) while AS does.

The lack of visible inflammation on an X-ray can lead to a delay in diagnosis, which can be done by a primary care physician or, better still, by a rheumatologist, Dr. Vista said.

Based on the International Map of Axial Spondyloarthritis (IMAS) online survey conducted in 2021, the average delay in diagnosis runs over seven years, with 81% of patients losing spinal mobility within the first 10 years of the disease.

“The age of onset is mid-20s, normally the most productive time of life. Late diagnosis and inadequate treatment have potential socioeconomic consequences,” he added.

The Axial Spondyloarthritis Association of the Philippines (ASAPh), the Philippine Rheumatology Association (PRA), and pharmaceutical company Novartis renewed their partnerships to strengthen public knowledge of AxSpA and its early diagnosis and treatment.

Got UR Back, a campaign headed by ASAPh, invites AxSpA patients to share their experiences of the condition for the medical community in the Philippines to listen to and act on. ASAPh has also encouraged patients to take the ongoing IMAS online survey, a global case study that seeks to shed light on the patient experience.

“There’s currently no government program for AxSpA,” said Clark Ferrer, President of ASAPh, who also suffers from the disease. “Our vision is to have a forum with the government, so we can have a healthcare policy to provide for Filipinos with AxSpA.”

He shared his own 21-year journey, from being bedridden due to frequent back pain to the decaying of his self-worth and mental health.

Dr. Juan Javier Lichauco, president of the PRA, acknowledged that AxSpA patients today have a better support system and newer treatment options: “The presence and development of biologics really changed the quality of life of our patients. They have the ability to address symptoms of pain now, and these drugs have the ability to stop the progression of disease.”

PRA also offers Clarrio, a mobile application that aims to help individuals suffering from chronic low back pain. Available for free on the App Store and Google Play, it allows users to categorize the level and nature of their pain and gives them tools to monitor and manage it. The app also connects to the PRA website, which lists over 200 rheumatologists and links to telemedicine services.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!



Have your team clocked less sick days during the pandemic but are now on the verge of burnout? You’re not alone … Providing right-first-time...


Have your team clocked less sick days during the pandemic but are now on the verge of burnout? You’re not alone … Providing right-first-time...


The UK government will invest £100m in Britishvolt as the car battery manufacturing startup seeks to build Britain’s first large-scale “gigafactory” in the north-east...


Bankers and accountants are among those being summoned back to their offices after the government scrapped its work-from-home guidance in England with immediate effect....


The kitchens of Michelin-starred restaurants too often descend into alternative “moral universes” where bullies and bad behaviour thrive, a study has suggested. While Gordon...


A company controlled by the Duke of York and used to manage his investments is more than £200,000 in debt, according to newly filed...

You May Also Like


THE PHILIPPINES is poised to end the year with a stronger economic growth, after a better-than-expected third quarter, experts said at the BusinessWorld Virtual...


The Philippines on Friday reported 310 coronavirus (COVID-19) infections, bringing the total number of infections to 2.84 million since the pandemic started in 2020....

Top News

Manufacturers face no dearth of options when it comes to bonding solutions in the modern era; however, over time, pressure sensitive adhesives are increasingly...

Top News

An integral component of the global economy, the automotive industry, a flourishing behemoth in itself, has been fraught with many challenges since the last...

Disclaimer:, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2022 InvestmentDiets. All Rights Reserved.